Mostrando 3 resultados de: 3
Filtros aplicados
Publisher
Maturitas(3)
Área temáticas
Enfermedades(2)
Ginecología, obstetricia, pediatría, geriatría(1)
Salud y seguridad personal(1)
Origen
scopus(3)
Bisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al.
OtherAbstract:Palabras claves:Autores:Anagnostis P., Ceausu I., Depypere H., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Mueck A., Paschou S.A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A.Fuentes:scopusEMAS position statement: Non-hormonal management of menopausal vasomotor symptoms
ArticleAbstract: Aim: To review non-hormonal therapy options for menopausal vasomotor symptoms. The current EMAS posiPalabras claves:Behavioral therapies, Gabapentin, MENOPAUSE, Non-hormonal management, Selective serotonin-reuptake inhibitors, vasomotor symptomsAutores:Ceausu I., Depypere H., Erel T., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Rees M., Schenck-Gustafsson K., Simoncini T., Trémollieres F.A.Fuentes:scopusDrug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement
ReviewAbstract: Background Bisphosphonates and denosumab are used extensively in the treatment of postmenopausal ostPalabras claves:Alendronate, Bisphosphonates, Denosumab, Drug holiday, Risedronate, Zoledronic acidAutores:Anagnostis P., Ceausu I., Depypere H., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Mueck A., Paschou S.A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A.Fuentes:scopus